Theratechnologies Resumes Shipment of Tesamorelin to EMD Serono
(firmenpresse) - MONTREAL, CANADA -- (Marketwired) -- 12/03/13 -- Theratechnologies Inc. (TSX: TH) is pleased to announce that it has resumed shipment of EGRIFTA™ (tesamorelin for injection) to EMD Serono in the United States today.
Moreover, Jubilant HollisterStier, the third-party contract manufacturer for tesamorelin, also informed Theratechnologies that the strike, which was initiated by employees working at its manufacturing site in Montreal, Canada, is now over.
About Theratechnologies
Theratechnologies (TSX: TH) is a biopharmaceutical company that specializes in innovative therapeutic peptide products, with an emphasis on growth-hormone releasing factor peptides. Further information about Theratechnologies is available on the Company's website at , on SEDAR at and on the Securities and Exchange Commission's website at .
Contacts:
Denis Boucher
NATIONAL Public Relations
514-843-2393
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 03.12.2013 - 21:53 Uhr
Sprache: Deutsch
News-ID 322430
Anzahl Zeichen: 0
contact information:
Town:
MONTREAL, CANADA
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 256 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Theratechnologies Resumes Shipment of Tesamorelin to EMD Serono"
steht unter der journalistisch-redaktionellen Verantwortung von
Theratechnologies Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
